Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis

American Journal of Pathology

Volumn 158, Issue 5, 2001, Pages 1677-1683

  Lüttges, Jutta ^a   Galehdari, Hamid ^b   Bröcker, Verena ^a   Schwarte Waldhoff, Irmgard ^b   Henne Bruns, Doris ^a   Klöppel, Günter ^a   Schmiegel, Wolff ^b   Hahn, Stephan A ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN P53; SMAD4 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARCINOGENESIS; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 9P; CHROMOSOME INACTIVATION; CHROMOSOME LOSS; CLINICAL ARTICLE; DISEASE COURSE; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; MALE; PANCREAS CARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0035004797     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64123-5     Document Type: Article

References (23)

1. Morphological lesions associated with human primary invasive carcinoma nonendocrine pancreas cancer
2. Relation of pancreatic duct hyperplasia to carcinoma
3. Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis
4. Pancreatic intraepithelial neoplasia (PanIN): A new nomenclature and classification system for pancreatic duct lesions
5. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease
6. p16 and K-ras mutations in the intraductal precursors of human pancreatic adenocarcinoma
7. K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers
8. Duct changes and K-ras mutations in the disease-free pancreas: Analysis of type, age relation and spatial distribution
9. The K-ras mutation pattern in pancreatic ductal adenocarcinoma is usually identical to that in associated normal, hyperplastic and metaplastic duct epithelium
10. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: Loss of intranuclear expression
11. Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas
12. Overexpression of p53 protein in adenocarcinoma of the pancreas
13. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma
14. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression
15. Genetic progression and divergence in pancreatic carcinoma
16. Whole genome amplification using a degenerate oligonucleotide primer allows hundreds of genotypes to be performed on less than one nanogram of genomic DNA
17. Ductal lesions in patients with chorionic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53
18. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation
19. Genetic progression in the pancreatic ducts
20. p53 and K-RAS alterations in pancreatic epithelial cell lesions
21. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions
22. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
23. Loss of chromosome 18q is an early event in pancreatic ductal tumorigenesis